Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee on Research on Women's Health.

                    The meeting will be open to the public as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (                    *http://videocast.nih.gov/​*).                

*Name of Committee:*                         Advisory Committee on Research on Women's Health.                    

*Date:*                         April 9, 2024.                    

*Time:*                         9:30 a.m. to 4:00 p.m.                    

*Agenda:*                         ORWH Director's Report, Panel discussion on the middle life health of women and menopause, Presentation from NIH Director, Presentation of three concepts for Advisory Committee clearance including NIH Office of Autoimmune Disease Research in ORWH (OADR-ORWH) and the NIH-Wide Women's Health Funding Opportunity.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).                    

*Contact Person:*                         Vivian Ota Wang, Ph.D., FACMG, CGC, Deputy Director, Office on Research for Women's Health, Division of Program Coordination, Planning and Strategic Initiatives, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 20892, 240-550-9892,                         *otawangv@nih.gov, samia.noursi@nih.gov.*

Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meetings. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

                        Information is also available on the Institute's/Center's home page:                         *https://orwh.od.nih.gov/​,*                         where an agenda and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Dated: February 22, 2024. 

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-04108 Filed 2-27-24; 8:45 am]

BILLING CODE 4140-01-P